Aetna expands coverage of Dendreon drug, stock jumps

(Reuters) - Health insurer Aetna Inc said on Friday it will pay for a greater number of patients to receive Provenge, a prostate cancer drug made by Dendreon Corp, sending Dendreon's shares up as much as 10 percent.

via Reuters: Health News Read More Here..